Cytek Biosciences's total assets for Q2 2025 were $493.32M, an increase of 2.22% from the previous quarter. CTKB total liabilities were $115.76M for the fiscal quarter, a 12.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.